Skip to main content
. 2022 Dec 14;29(Suppl):S319–S332. doi: 10.3350/cmh.2022.0366

Table 1.

Participant demographics of included studies

Study number Author Study design Mean age Sex (% female) Mean BMI Biopsy-proven NAFLD in total (n) Biopsy-proven NAFLD in exercise group (n)
1 Hickman et al. [16] RCT 48 38 34 21 9
2 Eckard et al. [17] RCT 50 39 35 56 9
3 Naimimohasses et al. [18] NRCT 58 60 35 50 16
4 O’Gorman et al. [19] NRCT* 60 71 36 24 16
5 Rezende et al. [22] RCT 55 100 33 40 19
6 Stine et al. [23] RCT 50 61 35 28 18
7 Houghton et al. [24] RCT 54 n.r. 33 24 12
8 Kistler et al. [20] Cross-sectional 48 63 n.r. 813 n.a.
9 Lahelma et al. [21] Cross-sectional 51 65 40 100 n.a.

BMI, body mass index; NAFLD, non-alcoholic fatty liver disease; RCT, randomized controlled trial; NRCT, non-randomized controlled trial; n.r., not reported; n.a., not applicable.

*

Non-randomized controlled trial design for non-invasive test endpoints; uncontrolled trial design for histological endpoints.